Latest Safety News

GrainCorp says its transformation program is on track to deliver $12 million in run-rate benefits by the end of FY26, above the top of its previous commitment. But the company has delayed a major systems rollout, expects $30-35 million of FY27 completion spend and deferred a second release.

A multimillion-dollar, multiyear NIH grant will fund an expanded access program for Neurizon’s investigational NUZ-001, potentially giving up to 200 US patients access to the therapy for as long as 96 weeks. The program is designed to add long-term safety, survival and biomarker data alongside the pivotal HEALEY ALS trial.

EV Resources has moved its Tecomatlán plant from integration into live proof-of-concept processing, with 200 metric tons of antimony ore delivered and crushing underway. The company is now targeting its first marketable antimony concentrate, although plant-scale performance remains unproven.

The FDA has agreed that EBR Systems’ WiSE cardiac pacing system does not require a field corrective action or recall following a February cybersecurity incident. The device maker says it has found no evidence of any impact on the safety or performance of fielded systems, while remediation work continues.

Polymetals Resources moved its Endeavor silver-zinc-lead mine from restart to commercial production in FY2026, generating A$100.0 million in revenue. The milestone came alongside a A$47.0 million loss, negative operating cash flow and an auditor warning over going-concern uncertainty.

Emperor Energy has signed a term sheet to secure the Valaris 107 jack-up rig for its Judith-2 appraisal well, targeted for April 2027. The deal commits US$3.5 million before the full drilling contract is finalised, while environmental approval remains outstanding.

Prescient Therapeutics has given shareholders another week to participate in its A$7 million share purchase plan, citing delayed documentation and requests for more time. The capital raising is intended to fund PTX-100 through a planned December 2026 Dose Optimisation Committee meeting.

Black Cat Syndicate has appointed mining veteran Chris Stone as Acting Managing Director, with the interim arrangement beginning immediately and running indefinitely. Stone will earn $600,000 a year plus superannuation while the company searches for a permanent appointment.

Elevra Lithium is positioning its Québec operations for a near-doubling in spodumene concentrate capacity, while guiding to modest production growth and sharply higher capital spending in FY27. The three-stage North American Lithium expansion is targeting 373,000 tonnes per year for an estimated US$271 million.

Emyria has reported a sharp increase in FY26 revenue while expanding its psychedelic-assisted therapy network to five operational or announced clinics and 18 beds. Its first Sydney clinic is now fitted out and scheduled to begin treating patients in September, but utilisation and funding remain the next tests.

Clever Culture Systems secures a follow-up order from Novo Nordisk for two APAS Independence instruments, marking a critical step toward broader global deployment and signalling expected sales growth from FY27.

Port of Tauranga has gained fast-track approval for its Stella Passage development, a key infrastructure project aimed at boosting freight capacity and supply chain efficiency in New Zealand.